New hope against superbug: antibiotic combo targets resistant klebsiella
NCT ID NCT07369518
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test the antibiotic combination ceftazidime-avibactam on 100 patients with healthcare-associated infections caused by carbapenem-resistant Klebsiella pneumoniae. Researchers will collect samples from blood, urine, and other sites to identify the bacteria and check for resistance genes. The goal is to see how well the drug works and understand the genetic makeup of these superbugs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ceftazidime-avibactam
What this could lead to
If successful, this could help doctors choose better antibiotics for hard-to-treat Klebsiella infections, potentially improving patient outcomes.
What could go wrong
This is a small, early-stage study that has not yet started recruiting. It focuses on lab testing and may not directly lead to new treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISOLATION OF KLEB. BY CULTURE ON MACCONKEY AGAR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Faculty of medicine Sohag University
Sohag, Egypt